Integrum AB

Equities

INTEG B

SE0009807266

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm Other stock markets 12:00:00 2024-12-10 pm EST			5-day change	1st Jan Change
19.75 ^SEK	+3.95%		-4.13%	-56.74%

Dec. 10	Carnegie brokers approximately 0.8 percent of the capital in Integrum	FW
Dec. 05	Redeye and Carnegie lower fair values for Integrum after report	FW

Integrum Enters a Commercial agreement with AMI Technologies to introduce the OPRATM Implant System in Israel

March 26, 2024 at 02:00 am EDT

Integrum (publ) announced that the company has entered a commercial agreement with AMI Technologies, to introduce the OPRATM Implant System in Israel. As part of Integrum's efforts to expand the availability of the OPRA? Implant System to new geographical markets, the company has started a collaboration in Israel with AMI Technologies.

Latest news about Integrum AB

Carnegie brokers approximately 0.8 percent of the capital in Integrum	Dec. 10	FW
Redeye and Carnegie lower fair values for Integrum after report	Dec. 05	FW
Redeye lowers motivated value for Integrum to SEK 37 (72)	Dec. 05	FW
Integrum - Q2 Presentation 2024	Dec. 04	FW
Affärsvärlden gives a neutral advice for Integrum	Dec. 04	FW
Carnegie brokers approximately 0.5 percent of the capital in Integrum	Dec. 04	FW
Integrum AB, Q2 2025 Earnings Call, Dec 04, 2024	Dec. 04
Stockholm Bullets - Volvo Cars rises on sales figures (update)	Dec. 04	FW
Stockholm Bullets - Volvo Cars rises on sales figures	Dec. 04	FW
Carnegie believes Integrum's interim results will support the share	Dec. 04	FW
Integrum reduces turnover and turns to loss	Dec. 04	FW
Integrum AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2024	Dec. 03	CI
Integrum launches service initiative to boost US growth	Nov. 28	FW
Integrum appoints Ty Hanners as US Sales Director	Oct. 07	FW
Integrum Names Interim COO	Sep. 18	MT
Inger Rydin appointed interim COO at Integrum	Sep. 18	FW
Inger Rydin Announces Executive Changes	Sep. 17	CI
Carnegie reiterates its motivated value for Integrum after the CEO shake-up	Sep. 16	FW
Integrum CEO to Step Down; Acting CEO Named	Sep. 16	MT
Integrum AB Appoints Rickard Brånemark as Chief Scientific Advisor	Sep. 15	CI
Integrum Announces Change in Chief Executive Officer	Sep. 15	CI
Lowered fair values for Integrum after disappointing report	Aug. 30	FW
Integrum's acting CFO Jörgen Svanström bought shares after the price drop	Aug. 30	FW
Redeye lowers motivated value for Integrum to SEK 72 (79)	Aug. 30	FW
Integrum - Q1 Presentation 23/24	Aug. 29	FW

Chart Integrum AB

Duration

Period

INTEG B: Dynamic Chart

Company Profile

Integrum AB is a Sweden-based company within healthcare sector. It provides systems for bone-anchored prostheses for individuals with amputations. The Companyâs solutions comprise OPRA Implant System, neural prosthetics, phantom limb pain treatment and prosthetic components. The OPRA implant system is based on osseointegration, enabling the direct connection of an artificial limb to the skeleton. The neural prosthetics technology implies ability to directly connect bionic prostheses to the patientâs bone, nerves, and muscles. A method for limb pain treatment implies motor execution of the phantom limb as a treatment, which is aided by machine learning, augmented and virtual reality. The Company provides a variety of prosthetic components required to connect the OPRA Implant System to external prostheses.

Employees

Sector

Medical Equipment, Supplies & Distribution

Calendar

2025-03-02 - Q3 2024 Earnings Release

More about the company